Lipid analysis of bronchoalveolar lavage fluid (BAL) by MALDI-TOF mass spectrometry and 31P NMR spectroscopy.
Despite the high clinical relevance, only the cellular moiety of bronchoalveolar lavage (BAL) has been intensively investigated and is used for diagnosis purposes. On the other hand, the cell-free fluid is, by far, less characterized. Although this fluid represents a relatively simple mixture of only a few different phospholipids (mainly phosphatidylcholine, phosphatidylglycerol and cholesterol), methods for the routine analysis of these fluids are still lacking. In the present investigation we have applied, for the first time, MALDI-TOF mass spectrometry, as well as 31P NMR spectroscopy to the analysis of organic extracts of bronchoalveolar lavage fluids. BAL from different mammals (rat, minipig, rabbit and man) were investigated and, for means of comparison, organic extracts of lung tissue were also examined. Both applied methods provide fast and reliable information on the lipid composition of the bronchoalveolar lavage. However, despite of its comparably low sensitivity, 31P NMR spectroscopy detects all phospholipid species in a single experiment and with the same sensitivity, whereas MALDI-TOF fails in the detection of phosphatidylethanolamine in the presence of higher quantities of phosphatidylcholine. In contrast, MALDI-TOF mass spectrometry is more suitable for the detection of cholesterol and the determination of the fatty acid composition of the individual phospholipids, especially lysolipids. It will be shown that all BALs exhibit significant, species-dependent differences that mainly concern the content of phosphatidylglycerol and lyso-phosphatidylcholine. It is concluded that both methods are suitable tools in lipid research due to the (in comparison to alternative methods) simplicity of performance.
Schiller
J
J
Institute of Medical Physics and Biophysics, Medical Department, University of Leipzig, Liebigstr. 27, D-04103 Leipzig, Germany. schij@server3.medizin.uni-leipzig.de
Hammerschmidt
S
S
Wirtz
H
H
Arnhold
J
J
Arnold
K
K
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D002784:Cholesterol / Q000032:analysis; D002794:Choline / Q000032:analysis; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000503:physiopathology; D008244:Lysophosphatidylcholines / Q000032:analysis; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008297:Male; D008479:Mediastinal Neoplasms / Q000503:physiopathology; D010713:Phosphatidylcholines / Q000032:analysis; D010715:Phosphatidylglycerols / Q000032:analysis; D010716:Phosphatidylinositols / Q000032:analysis; D010743:Phospholipids / Q000032:analysis*; D010758:Phosphorus; D011663:Pulmonary Surfactants / Q000737:chemistry* / Q000302:isolation & purification; D011817:Rabbits; D051381:Rats; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods; D013109:Sphingomyelins / Q000032:analysis; D013552:Swine; D013556:Swine, Miniature
D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; D010716:Phosphatidylinositols; D010743:Phospholipids; D011663:Pulmonary Surfactants; D013109:Sphingomyelins; D010758:Phosphorus; D002784:Cholesterol; D002794:Choline